【摘要】：子宮頸癌是婦科常見惡性腫瘤,不同于大多數(shù)婦科腫瘤的手術(shù)病理分期,宮頸癌主要采取臨床分期,依據(jù)仍主要依賴臨床醫(yī)師的體格檢查,存在一定的主觀性。核磁共振因其對(duì)軟組織具有高度辨識(shí)性,其直觀、無創(chuàng)、無輻射等優(yōu)點(diǎn)使其在臨床中得到廣泛應(yīng)用,隨著核磁共振技術(shù)的開發(fā),近年來功能性核磁共振即核磁共振彌散加權(quán)成像在臨床上的應(yīng)用越來越受到重視,被列為磁共振常規(guī)檢查序列。我們將從以下幾個(gè)方面闡述其在宮頸癌分期、評(píng)估宮頸癌治療效果方面的臨床應(yīng)用。
[Abstract]:Cervical cancer is a common malignant tumor of gynecology, which is different from the surgical and pathological stage of most gynecological tumors. Cervical cancer mainly adopts clinical stage, and still mainly depends on the physical examination of clinicians, and there is a certain subjectivity. Nuclear magnetic resonance (MRI) has been widely used in clinic because of its high identification of soft tissue, its intuitionistic, non-invasive, non-radiation and other advantages. With the development of nuclear magnetic resonance (MRI) technology, In recent years, more and more attention has been paid to the clinical application of functional nuclear magnetic resonance (fMRI) diffusion-weighted imaging (fMRI), which has been listed as routine magnetic resonance imaging (MRI) sequence. We will describe its clinical application in cervical cancer stage and evaluate the therapeutic effect of cervical cancer from the following aspects.
【學(xué)位授予單位】：重慶醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R445.2;R737.33

【參考文獻(xiàn)】

相關(guān)期刊論文 前6條

1 張潔;任翠;薛華丹;周海龍;孫照勇;金征宇;;彌散加權(quán)成像對(duì)宮頸癌淋巴結(jié)轉(zhuǎn)移的診斷價(jià)值[J];中國醫(yī)學(xué)科學(xué)院學(xué)報(bào);2014年01期

2 李建生;湯日杰;凌國輝;盧斌貴;張海南;;MRI在診斷宮頸癌復(fù)發(fā)中的價(jià)值[J];現(xiàn)代腫瘤醫(yī)學(xué);2012年04期

3 周凱;趙紅琴;施錚錚;王美豪;李又成;鄭飛云;盧山珊;;磁共振檢查在宮頸癌術(shù)前評(píng)估中的價(jià)值[J];溫州醫(yī)學(xué)院學(xué)報(bào);2012年01期

4 張海南;湯日杰;張書旭;蔡霜;;CT/MRI融合圖像在盆腔腫瘤放療靶區(qū)勾畫中的應(yīng)用[J];中國醫(yī)療設(shè)備;2011年05期

5 陳對(duì)梅;王峻;牛金亮;鄭英;;MRI評(píng)估宮頸癌宮旁侵犯和淋巴結(jié)轉(zhuǎn)移的價(jià)值[J];中國醫(yī)學(xué)影像技術(shù);2009年S1期

6 江新青,謝琦,夏建東,梁長虹,彭國暉,劉璋,張靜,葉偉軍,梁志偉,鄭力強(qiáng),鐘衛(wèi)紅,陳明旺;宮頸癌的MRI分析[J];中國醫(yī)學(xué)影像技術(shù);2003年03期

，

本文編號(hào)：2482412